Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 8:51 AM ET

Capital Markets

Company Overview of Warburg Pincus LLC

Company Overview

Warburg Pincus LLC is a private equity and venture capital firm specializing in all stages of a company’s life cycle from founding startups, early-stage financings, growth equity investments, and developing companies to restructurings, recapitalizations, late stage, and management buyouts of mature businesses. The firm also invests in change in control leveraged buyout transactions, divisional spin-outs of non-core corporate assets, minority private investments in public companies, and special situations transactions with a focus on acquisition of undervalued companies and middle market companies. It typically invests in financial services; healthcare; services; population health and account...

450 Lexington Avenue

34th Floor

New York, NY 10017-3147

United States

Founded in 1939

Phone:

212-878-0600

Fax:

212-878-9351

Key Executives for Warburg Pincus LLC

Co-Chief Executive Officer and Member of the Executive Management Group
Age: 50
Co-Chief Executive Officer and Member of Executive Management Group
Age: 53
President, Managing Director, and Member of Executive Management Group
Managing Director and Chief Financial Officer
Managing Director, Senior Advisor, and Vice Chairman
Age: 79
Compensation as of Fiscal Year 2014.

Warburg Pincus LLC Key Developments

Tata Sky Mulls Financing

Tata Sky Limited is seeking financing. Tata Sky has initiated talks with bulge bracket private equity firms to raise up to INR 18 billion after shelving its plans for an initial public offering ( IPO). The loss-making venture will use the capital for its technology upgradation and expansion, said four people with direct knowledge of the process. Citigroup Inc. (NYSE:C) and Morgan Stanley (NYSE:MS) have been retained but now the mandate is to raise PE funding, a person, who is a part of the process, said. "The company will now tap private equity players who can offer patient capital and can wait till the company turns profitable,"another person said. "Most of the global investors such as Bain Capital, LLC, The Blackstone Group L.P. (NYSE:BX), Warburg Pincus LLC, TPG Capital, L.P. and General Atlantic LLC have been approached." Economic Times could not independently verify these names. Confirming that the company has shelved its listing plans, Harit Nagpal, Chief Executive Officer of Tata Sky in an SMS response said, "All our cash requirements have been and will continue to be met by existing shareholders."

Warburg Pincus Submitted A Bid For Majority Stake In Sharekhan For INR 2-2.4 Billion

Warburg Pincus LLC has submitted a binding bid to buy a majority stake in Sharekhan Limited for INR 2-2.4 billion and the final agreement can be signed within few weeks. IndusInd Bank Limited (BSE:532187) had shown interest in Sharekhan but has pulled out from the deal now. The Rohatyn Group, LLC had put its 46% stake in Sharekhan up for sale last year.

Two Funds Are Reportedly In Talks To Buy Mankind Stake

ChrysCapital may sell its eight-year-old investment in Mankind Pharma Limited at a price that is nearly 10 times the value of its original investment. Capital International, Inc. (Capital International Private Equity Funds) and Warburg Pincus LLC are in the final stages of negotiation with ChrysCapital to buy its 11% stake in Mankind Pharma, according to two people familiar with the development. The deal size is estimated at around $225 million-$250 million, they said. “ChrysCapital has received serious pre-emptive offers from a couple of global PE funds that have been forwarded to the Juneja family, promoters of Mankind Pharma. As Fund-IV comes to an end, it is true that ChrysCapital is in talks with the Junejas to provide an exit for their investment in Mankind latest by the end of calendar year 2015,” said Sanjiv Kaul, managing director, ChrysCapital. ChrysCapital has appointed Ernst & Young (EY) and Avendus Capital Private Limited as bankers for the transaction, according to the first person cited above. The process will be completed by August 2015-September 2015, he said. Spokespeople for Warburg Pincus and Capital International declined to comment citing company policy, reported Mint, and Mankind declined to comment on the stake sale in an email, saying the company’s “spokesperson is travelling”.

Similar Private Companies By Industry

Company Name Region
West Texas Royalties Inc. United States
Kohler Capital III Corporation United States
Bytewatch Technologies Inc United States
Forum Acquisitions I, Inc. United States
Bellstone Commercial, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 21, 2015
52mf.com
Private Placement
May 5, 2015
Edaijia, Inc.
Private Placement
May 5, 2015
Outset Medical, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Warburg Pincus LLC, please visit www.warburgpincus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.